Ciphergen Biosystems KK markets and supplies protein chip systems and services for clinical, research and process proteomic applications. The company was founded in January, 1999 and is headquartered in Yokohama, Japan.

Bio Preventive Medicine Corp. is an clinical-staged biotech company, mainly focusing on early detection and prevention of diseases specialty of those high value added molecular diagnostic product. It offers DNlite-IVD103 and DNlite-DN_Score test on-invasive urinary test for monitoring the progression of diabetic nephropathy. The company was founded on June 15, 2014 and is headquartered in Zhubei, Taiwan.

Part of Meridian Hospital Co. Plc, Queen Elizabeth Hospital is a British company located in Woolwich. The firm operates as a hospital. Caroline Shaw has been the CEO since 2019. Queen Elizabeth Hospital was acquired by Meridian Hospital Co. Plc on July 01, 1998 for $194.89 million.

Vermilion, Inc. is an American private company located in Boulder, CO. The firm operates as an advertising agency specializes in audience research, brand development, web design & development services. It was founded by Bob Morehouse. Susan Touchette Aust is the current CEO, occupying that position since 1992.\nThe company says this about itself: Vermilion is a full-service, creative agency based in Boulder, Colorado, that provides distinctive and effective solutions exclusively to organizations that make a positive impact. As a Certified B Corporation, the agency is focused on helping purpose-driven brands grow and make a difference, supporting organizations advancing health and well-being, and connecting conservation and recreation in outdoor and environmental brands. Vermilion is also a Public Benefit Corporation, a specific type of corporation that allows for public benefit and social impact to be a charter purpose in addition to traditional corporate goals.

Intrinsic Bioprobes is a biotechnology company. Moreover, the company is a manufacturer of immuno-enrichment, sample-preparation tools used in quantitative mass spectrometry. Founded in 1996, the company is headquartered in Tempe, Arizona.

Institut Català d'Oncologia, a subsidiary of Region of Catalonia, is a company headquartered in Barcelona, Spain. The firm operates cancer research institute.

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment. The company is developing two unique programs such as drug candidate, X4P-001, has clinical experience in over 70 subjects, and is advancing into Phase 1/2 trials in refractory clear cell renal cell carcinoma (ccRCC) and refractory epithelial ovarian cancer (EOC), the second program, X4P-002, is a unique series of late lead molecules that penetrate the blood-brain barrier. They will pursue early clinical development in glioblastoma multiforme (GBM), a rare form of lethal brain cancer, for the X4P-002 program.

Immunovia is a strategic center for translational cancer research in Lund, Sweden. Immunovia’s strategy is to decipher a large amount of information in the blood and translate it into clinically useful tools to diagnose complex diseases such as cancer and to do this earlier and more accurately than previously possible. Immunovia’s core technology platform, IMMray™, is based on antibody microarray analysis.

BerGenBio ASA engages in the development of biopharmaceutical product for cancer therapy. It focuses on developing a pipeline of AXL kinase inhibitors. Its lead product bemcentinib, is a selective and orally bio-available small molecule AXL inhibitor. The company was founded by James Bradley Lorens and David R. Micklem on December 21, 2007 and is headquartered in Bergen, Norway.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Manufactures cancer diagnostics systems and products